---
source_path: H08GJ6-PDF-ENG.md
pages: n/a-n/a
chunk_id: e4e2e14ab0551a1e3ed8b661975d6cb6fa896c31
title: H08GJ6-PDF-ENG
---
## parallel. The tighter the budget constraint — think, for example, of the

extreme selectivity of pharmaceutical companies when they populate

their portfolio of clinical trials — the greater the importance of choosing

a rule that can identify the best project(s) among many candidates

To that end, we considered some of the common ways organizations

make these innovation project decisions:
